These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 488008)

  • 1. Glucose infusion potentiates the acute insulin response to nonglucose stimuli during the infusion of somatostatin.
    Taborsky GJ; Smith PH; Halter JB; Porte D
    Endocrinology; 1979 Nov; 105(5):1215-20. PubMed ID: 488008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of insulin secretion to nonglucose stimuli in normal man by tolbutamide.
    Pfeifer MA; Halter JB; Graf R; Porte D
    Diabetes; 1980 May; 29(5):335-40. PubMed ID: 6991327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extrapancreatic effect of somatostatin infusion to increase glucose clearance.
    Bergman RN; Ader M; Finegood DT; Pacini G
    Am J Physiol; 1984 Sep; 247(3 Pt 1):E370-9. PubMed ID: 6148014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin responses to nonglucose stimuli in non-insulin-dependent diabetes mellitus during a tolbutamide infusion.
    Pfeifer MA; Halter JB; Beard JC; Judzewitsch R; Porte D
    Diabetes; 1982 Feb; 31(2):154-9. PubMed ID: 6759232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation between glucose-induced desensitization of insulin secretion and beta-cell exhaustion in the HIT-T15 cell line.
    Kilpatrick ED; Robertson RP
    Diabetes; 1998 Apr; 47(4):606-11. PubMed ID: 9568694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of somatostatin and glucose infusion on glucose kinetics in fetal sheep.
    Bloch CA; Menon RK; Sperling MA
    Am J Physiol; 1988 Jul; 255(1 Pt 1):E87-93. PubMed ID: 2898894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for endogenous prostaglandins in defective glucose potentiation of nonglucose insulin secretagogues in diabetics.
    McRae JR; Metz SA; Robertson RP
    Metabolism; 1981 Nov; 30(11):1065-75. PubMed ID: 7026970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pancreatic glucagon and C-peptide secretion during hyperinsulinemia in euglycemic glucose clamp with or without somatostatin infusion in normal man.
    Wu MS; Ho LT
    Horm Metab Res; 1987 Jun; 19(6):253-6. PubMed ID: 2887501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic response to insulin in control of glucose kinetics in the neonatal lamb.
    Cowett RM; Tenenbaum D
    Metabolism; 1987 Nov; 36(11):1021-6. PubMed ID: 2890078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin does not increase insulin-stimulated glucose uptake in humans.
    Baron AD; Wallace P; Brechtel G; Prager R
    Diabetes; 1987 Jan; 36(1):33-6. PubMed ID: 2878848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of somatostatin and two of its analogues on basal and arginine-stimulated insulin and glucagon secretion in the dog.
    Buchs A; Märki F; Keller U
    Regul Pept; 1982 Aug; 4(3):117-26. PubMed ID: 6127755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of lysine acetylsalicylate on somatostatin inhibition of insulin secretion induced by arginine.
    Altomonte L; Zoli A; Accili D; Ghirlanda G; Manna R; Bertoli A; Greco AV
    Exp Clin Endocrinol; 1986 Nov; 88(1):119-22. PubMed ID: 2880743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of somatostatin in regulating pancreatic splenic lobe hormone secretion following 99% pancreatectomy in adult chickens.
    Cieslak SR; Hazelwood RL
    Gen Comp Endocrinol; 1986 Aug; 63(2):284-94. PubMed ID: 2877920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of insulin in the blunted glucose metabolic response of septic rats to epinephrine.
    Hargrove DM; Skrepnik N; Lang CH; Bagby GJ; Spitzer JJ
    Metabolism; 1990 Nov; 39(11):1180-5. PubMed ID: 1978224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans.
    Broglio F; Koetsveld Pv Pv; Benso A; Gottero C; Prodam F; Papotti M; Muccioli G; Gauna C; Hofland L; Deghenghi R; Arvat E; Van Der Lely AJ; Ghigo E
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4829-32. PubMed ID: 12364482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between insulin-mediated glucose disposal by muscle and adipose tissue lipolysis in healthy volunteers.
    Pei D; Chen YD; Hollenbeck CB; Bhargava R; Reaven GM
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3368-72. PubMed ID: 7593453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cyclic somatostatin on insulin, C-peptide and immunoreactive glucagon response to oral glucose loading in obese patients.
    Papalia D; Trovato G; Maugeri D; Tribulato A; Lunetta M
    Int J Obes; 1982; 6(1):113-20. PubMed ID: 6121763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intracellular glucopenia on pulsatile growth hormone secretion: mediation in part by somatostatin.
    Painson JC; Tannenbaum GS
    Endocrinology; 1985 Sep; 117(3):1132-8. PubMed ID: 2862015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal plasma insulin and thyroid hormone levels during acute in utero ethanol exposure in a maternal-fetal sheep model.
    Castro MI; Koritnik DR; Rose JC
    Endocrinology; 1986 May; 118(5):1735-42. PubMed ID: 3084206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin potentiation of insulin-induced glucose uptake in normal individuals.
    Wu MS; Ho LT; Chen JJ; Chen YD; Reaven GM
    Am J Physiol; 1986 Dec; 251(6 Pt 1):E674-9. PubMed ID: 2878619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.